Evidence-based clinical practice guidelines for peptic ulcer disease 2020
The Japanese Society of Gastroenterology (JSGE) revised the third edition of evidence-based clinical practice guidelines for peptic ulcer disease in 2020 and created an English version. The revised guidelines consist of nine items: epidemiology, hemorrhagic gastric and duodenal ulcers, Helicobacter...
Saved in:
| Published in | Journal of gastroenterology Vol. 56; no. 4; pp. 303 - 322 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Singapore
Springer Singapore
01.04.2021
Springer Springer Nature B.V |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0944-1174 1435-5922 1435-5922 |
| DOI | 10.1007/s00535-021-01769-0 |
Cover
| Abstract | The Japanese Society of Gastroenterology (JSGE) revised the third edition of evidence-based clinical practice guidelines for peptic ulcer disease in 2020 and created an English version. The revised guidelines consist of nine items: epidemiology, hemorrhagic gastric and duodenal ulcers,
Helicobacter pylori
(
H. pylori
) eradication therapy, non-eradication therapy, drug-induced ulcers, non
-H. pylori,
and nonsteroidal anti-inflammatory drug (NSAID) ulcers, remnant gastric ulcers, surgical treatment, and conservative therapy for perforation and stenosis. Therapeutic algorithms for the treatment of peptic ulcers differ based on ulcer complications. In patients with NSAID-induced ulcers, NSAIDs are discontinued and anti-ulcer therapy is administered. If NSAIDs cannot be discontinued, the ulcer is treated with proton pump inhibitors (PPIs). Vonoprazan (VPZ) with antibiotics is recommended as the first-line treatment for
H. pylori
eradication, and PPIs or VPZ with antibiotics is recommended as a second-line therapy. Patients who do not use NSAIDs and are
H. pylori
negative are considered to have idiopathic peptic ulcers. Algorithms for the prevention of NSAID- and low-dose aspirin (LDA)-related ulcers are presented in this guideline. These algorithms differ based on the concomitant use of LDA or NSAIDs and ulcer history or hemorrhagic ulcer history. In patients with a history of ulcers receiving NSAID therapy, PPIs with or without celecoxib are recommended and the administration of VPZ is suggested for the prevention of ulcer recurrence. In patients with a history of ulcers receiving LDA therapy, PPIs or VPZ are recommended and the administration of a histamine 2-receptor antagonist is suggested for the prevention of ulcer recurrence. |
|---|---|
| AbstractList | The Japanese Society of Gastroenterology (JSGE) revised the third edition of evidence-based clinical practice guidelines for peptic ulcer disease in 2020 and created an English version. The revised guidelines consist of nine items: epidemiology, hemorrhagic gastric and duodenal ulcers,
Helicobacter pylori
(
H. pylori
) eradication therapy, non-eradication therapy, drug-induced ulcers, non
-H. pylori,
and nonsteroidal anti-inflammatory drug (NSAID) ulcers, remnant gastric ulcers, surgical treatment, and conservative therapy for perforation and stenosis. Therapeutic algorithms for the treatment of peptic ulcers differ based on ulcer complications. In patients with NSAID-induced ulcers, NSAIDs are discontinued and anti-ulcer therapy is administered. If NSAIDs cannot be discontinued, the ulcer is treated with proton pump inhibitors (PPIs). Vonoprazan (VPZ) with antibiotics is recommended as the first-line treatment for
H. pylori
eradication, and PPIs or VPZ with antibiotics is recommended as a second-line therapy. Patients who do not use NSAIDs and are
H. pylori
negative are considered to have idiopathic peptic ulcers. Algorithms for the prevention of NSAID- and low-dose aspirin (LDA)-related ulcers are presented in this guideline. These algorithms differ based on the concomitant use of LDA or NSAIDs and ulcer history or hemorrhagic ulcer history. In patients with a history of ulcers receiving NSAID therapy, PPIs with or without celecoxib are recommended and the administration of VPZ is suggested for the prevention of ulcer recurrence. In patients with a history of ulcers receiving LDA therapy, PPIs or VPZ are recommended and the administration of a histamine 2-receptor antagonist is suggested for the prevention of ulcer recurrence. The Japanese Society of Gastroenterology (JSGE) revised the third edition of evidence-based clinical practice guidelines for peptic ulcer disease in 2020 and created an English version. The revised guidelines consist of nine items: epidemiology, hemorrhagic gastric and duodenal ulcers, Helicobacter pylori (H. pylori) eradication therapy, non-eradication therapy, drug-induced ulcers, non-H. pylori, and nonsteroidal anti-inflammatory drug (NSAID) ulcers, remnant gastric ulcers, surgical treatment, and conservative therapy for perforation and stenosis. Therapeutic algorithms for the treatment of peptic ulcers differ based on ulcer complications. In patients with NSAID-induced ulcers, NSAIDs are discontinued and anti-ulcer therapy is administered. If NSAIDs cannot be discontinued, the ulcer is treated with proton pump inhibitors (PPIs). Vonoprazan (VPZ) with antibiotics is recommended as the first-line treatment for H. pylori eradication, and PPIs or VPZ with antibiotics is recommended as a second-line therapy. Patients who do not use NSAIDs and are H. pylori negative are considered to have idiopathic peptic ulcers. Algorithms for the prevention of NSAID- and low-dose aspirin (LDA)-related ulcers are presented in this guideline. These algorithms differ based on the concomitant use of LDA or NSAIDs and ulcer history or hemorrhagic ulcer history. In patients with a history of ulcers receiving NSAID therapy, PPIs with or without celecoxib are recommended and the administration of VPZ is suggested for the prevention of ulcer recurrence. In patients with a history of ulcers receiving LDA therapy, PPIs or VPZ are recommended and the administration of a histamine 2-receptor antagonist is suggested for the prevention of ulcer recurrence. The Japanese Society of Gastroenterology (JSGE) revised the third edition of evidence-based clinical practice guidelines for peptic ulcer disease in 2020 and created an English version. The revised guidelines consist of nine items: epidemiology, hemorrhagic gastric and duodenal ulcers, Helicobacter pylori (H. pylori) eradication therapy, non-eradication therapy, drug-induced ulcers, non-H. pylori, and nonsteroidal anti-inflammatory drug (NSAID) ulcers, remnant gastric ulcers, surgical treatment, and conservative therapy for perforation and stenosis. Therapeutic algorithms for the treatment of peptic ulcers differ based on ulcer complications. In patients with NSAID-induced ulcers, NSAIDs are discontinued and anti-ulcer therapy is administered. If NSAIDs cannot be discontinued, the ulcer is treated with proton pump inhibitors (PPIs). Vonoprazan (VPZ) with antibiotics is recommended as the first-line treatment for H. pylori eradication, and PPIs or VPZ with antibiotics is recommended as a second-line therapy. Patients who do not use NSAIDs and are H. pylori negative are considered to have idiopathic peptic ulcers. Algorithms for the prevention of NSAID- and low-dose aspirin (LDA)-related ulcers are presented in this guideline. These algorithms differ based on the concomitant use of LDA or NSAIDs and ulcer history or hemorrhagic ulcer history. In patients with a history of ulcers receiving NSAID therapy, PPIs with or without celecoxib are recommended and the administration of VPZ is suggested for the prevention of ulcer recurrence. In patients with a history of ulcers receiving LDA therapy, PPIs or VPZ are recommended and the administration of a histamine 2-receptor antagonist is suggested for the prevention of ulcer recurrence.The Japanese Society of Gastroenterology (JSGE) revised the third edition of evidence-based clinical practice guidelines for peptic ulcer disease in 2020 and created an English version. The revised guidelines consist of nine items: epidemiology, hemorrhagic gastric and duodenal ulcers, Helicobacter pylori (H. pylori) eradication therapy, non-eradication therapy, drug-induced ulcers, non-H. pylori, and nonsteroidal anti-inflammatory drug (NSAID) ulcers, remnant gastric ulcers, surgical treatment, and conservative therapy for perforation and stenosis. Therapeutic algorithms for the treatment of peptic ulcers differ based on ulcer complications. In patients with NSAID-induced ulcers, NSAIDs are discontinued and anti-ulcer therapy is administered. If NSAIDs cannot be discontinued, the ulcer is treated with proton pump inhibitors (PPIs). Vonoprazan (VPZ) with antibiotics is recommended as the first-line treatment for H. pylori eradication, and PPIs or VPZ with antibiotics is recommended as a second-line therapy. Patients who do not use NSAIDs and are H. pylori negative are considered to have idiopathic peptic ulcers. Algorithms for the prevention of NSAID- and low-dose aspirin (LDA)-related ulcers are presented in this guideline. These algorithms differ based on the concomitant use of LDA or NSAIDs and ulcer history or hemorrhagic ulcer history. In patients with a history of ulcers receiving NSAID therapy, PPIs with or without celecoxib are recommended and the administration of VPZ is suggested for the prevention of ulcer recurrence. In patients with a history of ulcers receiving LDA therapy, PPIs or VPZ are recommended and the administration of a histamine 2-receptor antagonist is suggested for the prevention of ulcer recurrence. |
| Audience | Academic |
| Author | Nomura, Sachiyo Ito, Masanori Kamada, Tomoari Sugimoto, Mitsushige Satoh, Kiichi Yoshino, Junji Watanabe, Sumio Koike, Kazuhiko Mieda, Mitsuyo Chiba, Toshimi Okimoto, Tadayoshi Takagi, Atsushi Itoh, Toshiyuki Iwamoto, Junichi Kanno, Takeshi Hiraishi, Hideyuki |
| Author_xml | – sequence: 1 givenname: Tomoari surname: Kamada fullname: Kamada, Tomoari email: tkamada@med.kawasaki-m.ac.jp organization: Department of Health Care Medicine, Kawasaki Medical School General Medical Center, Guidelines Committee for Creating and Evaluating the ‘‘Evidence-Based Clinical Practice Guidelines for Peptic Ulcer,” the Japanese Society of Gastroenterology (JSGE) – sequence: 2 givenname: Kiichi surname: Satoh fullname: Satoh, Kiichi organization: Guidelines Committee for Creating and Evaluating the ‘‘Evidence-Based Clinical Practice Guidelines for Peptic Ulcer,” the Japanese Society of Gastroenterology (JSGE) – sequence: 3 givenname: Toshiyuki surname: Itoh fullname: Itoh, Toshiyuki organization: Guidelines Committee for Creating and Evaluating the ‘‘Evidence-Based Clinical Practice Guidelines for Peptic Ulcer,” the Japanese Society of Gastroenterology (JSGE) – sequence: 4 givenname: Masanori surname: Ito fullname: Ito, Masanori organization: Guidelines Committee for Creating and Evaluating the ‘‘Evidence-Based Clinical Practice Guidelines for Peptic Ulcer,” the Japanese Society of Gastroenterology (JSGE) – sequence: 5 givenname: Junichi surname: Iwamoto fullname: Iwamoto, Junichi organization: Guidelines Committee for Creating and Evaluating the ‘‘Evidence-Based Clinical Practice Guidelines for Peptic Ulcer,” the Japanese Society of Gastroenterology (JSGE) – sequence: 6 givenname: Tadayoshi surname: Okimoto fullname: Okimoto, Tadayoshi organization: Guidelines Committee for Creating and Evaluating the ‘‘Evidence-Based Clinical Practice Guidelines for Peptic Ulcer,” the Japanese Society of Gastroenterology (JSGE) – sequence: 7 givenname: Takeshi surname: Kanno fullname: Kanno, Takeshi organization: Guidelines Committee for Creating and Evaluating the ‘‘Evidence-Based Clinical Practice Guidelines for Peptic Ulcer,” the Japanese Society of Gastroenterology (JSGE) – sequence: 8 givenname: Mitsushige surname: Sugimoto fullname: Sugimoto, Mitsushige organization: Guidelines Committee for Creating and Evaluating the ‘‘Evidence-Based Clinical Practice Guidelines for Peptic Ulcer,” the Japanese Society of Gastroenterology (JSGE) – sequence: 9 givenname: Toshimi surname: Chiba fullname: Chiba, Toshimi organization: Guidelines Committee for Creating and Evaluating the ‘‘Evidence-Based Clinical Practice Guidelines for Peptic Ulcer,” the Japanese Society of Gastroenterology (JSGE) – sequence: 10 givenname: Sachiyo surname: Nomura fullname: Nomura, Sachiyo organization: Guidelines Committee for Creating and Evaluating the ‘‘Evidence-Based Clinical Practice Guidelines for Peptic Ulcer,” the Japanese Society of Gastroenterology (JSGE) – sequence: 11 givenname: Mitsuyo surname: Mieda fullname: Mieda, Mitsuyo organization: Guidelines Committee for Creating and Evaluating the ‘‘Evidence-Based Clinical Practice Guidelines for Peptic Ulcer,” the Japanese Society of Gastroenterology (JSGE) – sequence: 12 givenname: Hideyuki surname: Hiraishi fullname: Hiraishi, Hideyuki organization: Guidelines Committee for Creating and Evaluating the ‘‘Evidence-Based Clinical Practice Guidelines for Peptic Ulcer,” the Japanese Society of Gastroenterology (JSGE) – sequence: 13 givenname: Junji surname: Yoshino fullname: Yoshino, Junji organization: Guidelines Committee for Creating and Evaluating the ‘‘Evidence-Based Clinical Practice Guidelines for Peptic Ulcer,” the Japanese Society of Gastroenterology (JSGE) – sequence: 14 givenname: Atsushi surname: Takagi fullname: Takagi, Atsushi organization: Guidelines Committee for Creating and Evaluating the ‘‘Evidence-Based Clinical Practice Guidelines for Peptic Ulcer,” the Japanese Society of Gastroenterology (JSGE) – sequence: 15 givenname: Sumio surname: Watanabe fullname: Watanabe, Sumio organization: Guidelines Committee for Creating and Evaluating the ‘‘Evidence-Based Clinical Practice Guidelines for Peptic Ulcer,” the Japanese Society of Gastroenterology (JSGE) – sequence: 16 givenname: Kazuhiko surname: Koike fullname: Koike, Kazuhiko organization: Guidelines Committee for Creating and Evaluating the ‘‘Evidence-Based Clinical Practice Guidelines for Peptic Ulcer,” the Japanese Society of Gastroenterology (JSGE) |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33620586$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kk1v1DAQhi1URLeFP8ABReLCJWX8nVyQqqpApUpcerccZ7K4ytrBTirx7-t0l0IrVPlga_y873jGc0KOQgxIyHsKZxRAf84AkssaGK2BatXW8IpsqCgh2TJ2RDbQClFTqsUxOcn5FoBykM0bcsy5YuWkNuTq8s73GBzWnc3YV270wTs7VlOybvYOq-1SgBLFXA0xVRNOJVwto8NU9T5jkVUMGLwlrwc7Znx32E_JzdfLm4vv9fWPb1cX59e1U5zONXZaaC2ZoK5zCD2TtGm01Fz1TXk60rbcCqEkYutAc2G7lWqYbLpmGPgp-bK3nZZuh73DMCc7min5nU2_TbTePL0J_qfZxjvTrN1q22Lw6WCQ4q8F82x2PjscRxswLtkw0TKlgCtZ0I_P0Nu4pFCqM0yColSqB8MDtbUjGh-GWPK61dScaypkw1pYvc7-Q5XV48678rGDL_Engg__FvpY4Z-_KwDbAy7FnBMOjwgFsw6I2Q-IKQNiHgbEQBE1z0TOz3b2cW2WH1-W8r00lzxhi-lvN15Q3QObfMvJ |
| CitedBy_id | crossref_primary_10_1111_jgh_16000 crossref_primary_10_1192_bja_2022_62 crossref_primary_10_3390_life12101505 crossref_primary_10_1021_acs_jafc_3c08188 crossref_primary_10_3390_diagnostics12102364 crossref_primary_10_1007_s00535_023_01966_z crossref_primary_10_1093_jrr_rrad071 crossref_primary_10_3389_fsurg_2023_1099457 crossref_primary_10_47582_jompac_1341805 crossref_primary_10_3389_fphar_2024_1407435 crossref_primary_10_3390_cells10123530 crossref_primary_10_3390_molecules29091944 crossref_primary_10_1016_j_nutos_2024_08_008 crossref_primary_10_1186_s12893_023_02005_7 crossref_primary_10_1177_20420986241260211 crossref_primary_10_1007_s11096_022_01416_5 crossref_primary_10_14309_ctg_0000000000000804 crossref_primary_10_1016_j_gie_2024_10_002 crossref_primary_10_1159_000540185 crossref_primary_10_2196_68509 crossref_primary_10_1016_j_joim_2024_12_003 crossref_primary_10_1186_s40780_024_00357_7 crossref_primary_10_3390_medicina59010092 crossref_primary_10_1002_adma_202307601 crossref_primary_10_1002_phar_2899 crossref_primary_10_1016_j_jep_2021_114792 crossref_primary_10_1038_s41598_024_63928_6 crossref_primary_10_1097_SLE_0000000000001086 crossref_primary_10_1002_aoc_7520 crossref_primary_10_1186_s12876_024_03541_z crossref_primary_10_1007_s00109_024_02429_5 crossref_primary_10_1093_jjco_hyad024 crossref_primary_10_1111_apt_17070 crossref_primary_10_1177_17562848241275318 crossref_primary_10_1016_j_pedneo_2024_06_014 crossref_primary_10_1097_MJT_0000000000001439 crossref_primary_10_1016_j_ijscr_2024_109714 crossref_primary_10_1155_2022_4710964 crossref_primary_10_2147_IDR_S487503 crossref_primary_10_31146_1682_8658_ecg_207_11_160_170 crossref_primary_10_18502_wkmj_v66i2_16461 crossref_primary_10_19163_1994_9480_2023_20_1_140_151 crossref_primary_10_3390_jcm13206283 crossref_primary_10_3389_fphar_2022_909168 crossref_primary_10_1016_j_sjbs_2022_01_031 crossref_primary_10_1186_s12876_024_03265_0 crossref_primary_10_1016_j_jep_2023_116417 crossref_primary_10_1002_jsfa_13687 crossref_primary_10_1016_j_jaim_2024_100947 crossref_primary_10_1186_s13568_024_01783_4 crossref_primary_10_1016_j_addr_2023_115051 crossref_primary_10_3389_fphar_2023_1304552 crossref_primary_10_35339_ekm_2023_92_3_ivb crossref_primary_10_14309_ctg_0000000000000754 crossref_primary_10_24884_0042_4625_2022_181_2_24_32 crossref_primary_10_2147_IJGM_S353098 crossref_primary_10_3748_wjg_v29_i44_5882 crossref_primary_10_1111_cts_13772 crossref_primary_10_7704_kjhugr_2024_0075 crossref_primary_10_1186_s12872_024_04385_x crossref_primary_10_5492_wjccm_v14_i1_101639 crossref_primary_10_1016_j_ijscr_2025_111020 crossref_primary_10_3164_jcbn_24_56 crossref_primary_10_1111_apt_17133 crossref_primary_10_12998_wjcc_v12_i21_4574 crossref_primary_10_1016_j_fitote_2025_106397 crossref_primary_10_14309_ctg_0000000000000602 crossref_primary_10_2147_JIR_S436653 crossref_primary_10_1111_hel_12886 crossref_primary_10_1186_s12887_023_03957_8 crossref_primary_10_3390_healthcare11212853 crossref_primary_10_1016_j_jfma_2024_04_011 crossref_primary_10_1016_j_tox_2023_153596 crossref_primary_10_1371_journal_pone_0305320 crossref_primary_10_2169_internalmedicine_1508_22 crossref_primary_10_3389_fonc_2025_1521868 crossref_primary_10_17235_reed_2022_9228_2022 crossref_primary_10_1007_s12664_023_01501_1 crossref_primary_10_1007_s00210_022_02381_6 crossref_primary_10_1016_j_radcr_2024_06_032 crossref_primary_10_4103_jimr_jimr_23_23 crossref_primary_10_1177_17562848231167858 crossref_primary_10_1208_s12249_023_02693_7 crossref_primary_10_3389_fphar_2023_1269125 crossref_primary_10_3389_fnut_2024_1436993 crossref_primary_10_1021_acsnano_2c05247 crossref_primary_10_2169_internalmedicine_9646_22 crossref_primary_10_1111_hel_13046 crossref_primary_10_1159_000530472 crossref_primary_10_3390_vaccines11061087 crossref_primary_10_1097_MOG_0000000000000775 crossref_primary_10_37699_2308_7005_2_3_2024_23 crossref_primary_10_11569_wcjd_v30_i13_599 crossref_primary_10_1007_s10787_024_01544_6 crossref_primary_10_1186_s12885_021_08795_4 crossref_primary_10_3892_etm_2024_12699 crossref_primary_10_1016_j_crphar_2022_100147 crossref_primary_10_3389_fphar_2024_1477633 crossref_primary_10_1093_ejcts_ezac124 crossref_primary_10_1016_j_cej_2024_155700 crossref_primary_10_1002_cpdd_1053 crossref_primary_10_1080_03007995_2024_2414090 crossref_primary_10_1371_journal_pone_0270252 crossref_primary_10_3390_ph17060698 crossref_primary_10_1186_s12906_024_04702_z crossref_primary_10_1007_s40264_022_01150_x crossref_primary_10_1007_s00068_023_02387_6 crossref_primary_10_1177_20503121231220809 crossref_primary_10_1248_bpb_b24_00011 crossref_primary_10_1016_j_jep_2022_115258 crossref_primary_10_7759_cureus_56359 crossref_primary_10_1016_S0140_6736_24_00155_7 crossref_primary_10_3390_scipharm93010008 crossref_primary_10_5005_jp_journals_10030_1410 crossref_primary_10_3389_fcimb_2022_935681 crossref_primary_10_3892_etm_2023_11971 crossref_primary_10_1007_s13318_022_00810_8 crossref_primary_10_1080_14656566_2021_1959914 crossref_primary_10_2147_JIR_S504930 crossref_primary_10_23736_S2724_5985_24_03634_9 crossref_primary_10_4240_wjgs_v15_i12_2757 crossref_primary_10_1097_MD_0000000000032281 crossref_primary_10_1016_j_stem_2024_08_009 crossref_primary_10_1080_14740338_2023_2136163 crossref_primary_10_1016_j_jep_2024_117901 crossref_primary_10_4292_wjgpt_v16_i1_101753 crossref_primary_10_1155_2022_6134128 crossref_primary_10_1016_j_phymed_2023_154954 crossref_primary_10_19163_1994_9480_2022_19_4_22_33 crossref_primary_10_12998_wjcc_v12_i8_1530 crossref_primary_10_2169_internalmedicine_0614_22 crossref_primary_10_7704_kjhugr_2025_0004 crossref_primary_10_31146_1682_8658_ecg_201_5_5_11 |
| Cites_doi | 10.1111/j.1365-2036.2006.02912.x 10.1053/j.gastro.2016.09.006 10.3748/wjg.v23.i4.668 10.1136/gutjnl-2015-311304 10.1007/s00535-012-0541-z 10.1111/apt.12174 10.1053/j.gastro.2009.09.063 10.1016/S0140-6736(07)61909-6 10.1016/j.clinthera.2004.10.002 10.1093/rheumatology/32.6.474 10.1016/S0140-6736(99)02332-6 10.1038/ajg.2012.87 10.3748/wjg.v21.i17.5382 10.1371/journal.pone.0131558 10.1016/S0149-2918(97)80098-7 10.1007/s00535-011-0397-7 10.1155/2009/191706 10.1016/S0140-6736(02)07272-0 10.1053/j.gastro.2009.05.006 10.1093/eurheartj/ehx419 10.1053/j.gastro.2004.05.001 10.1136/hrt.2010.217547 10.1136/gutjnl-2019-318715 10.1111/jgh.12442 10.1001/jama.296.13.jrv60011 10.1111/hel.12286 10.1093/rheumatology/keg359 10.1056/NEJMoa012877 10.1111/j.1523-5378.2011.00928.x 10.1046/j.1365-2036.2000.00822.x 10.3748/wjg.14.4535 10.1016/S1590-8658(00)80402-8 10.1056/NEJM200103293441304 10.1111/j.1365-2036.2010.04378.x 10.7326/0003-4819-152-1-201001050-00179 10.1136/gutjnl-2013-304722 10.1007/BF02088227 10.1016/S0016-5085(99)70334-3 10.3389/fphar.2018.01560 10.1055/s-0034-1365235 10.1016/S0140-6736(17)30981-9 10.1136/gutjnl-2016-312288 10.1007/s00268-005-7797-x 10.1111/jgh.12768 10.5152/tjg.2018.17143 10.3390/jcm9020543 10.1007/s00535-012-0588-x 10.1111/den.13184 10.1046/j.1365-2036.2003.01650.x 10.1159/000454762 10.1016/j.ahj.2011.08.007 10.1111/bcp.12866 10.1186/1471-230X-2-17 10.1016/S0140-6736(09)61246-0 10.1007/s00535-014-1016-1 10.1111/j.1365-2036.2005.02546.x 10.1007/s00535-012-0731-8 10.1016/j.cgh.2007.06.009 10.1038/ajg.2011.385 10.1038/ajg.2015.439 10.1007/s40262-015-0326-7 10.1097/00000658-200002000-00001 10.1016/j.cgh.2011.05.020 10.3748/wjg.v21.i2.661 10.1186/s13017-019-0223-8 10.2169/internalmedicine.56.7833 10.1253/circj.CJ-12-0511 10.1111/j.1572-0241.1998.00279.x 10.1111/hel.12597 10.1016/j.ijsu.2008.12.001 10.3892/etm.2016.3693 10.1038/ajg.2017.195 10.1111/apt.13642 10.1056/NEJMoa1611593 10.1111/apt.13876 10.1111/j.1365-2036.2012.05133.x 10.1053/j.gastro.2014.06.007 10.1007/BF01308523 10.1186/ar2207 10.1056/NEJMoa1007964 10.1111/j.1365-2036.2005.02444.x 10.1016/S0140-6736(07)60749-1 10.1056/NEJM199803123381105 10.1111/den.12635 10.1136/gutjnl-2017-314010 10.1001/archinte.160.10.1455 10.1056/NEJM199605303342204 10.1111/den.12183 10.1111/j.1523-5378.2012.00942.x 10.1111/apt.12907 10.1136/gut.34.6.762 10.1046/j.0007-1323.2001.01831.x 10.1136/gutjnl-2017-314852 10.1016/S2468-1253(18)30037-2 10.1053/j.gastro.2016.08.054 10.1111/j.1523-5378.2007.00508.x |
| ContentType | Journal Article |
| Copyright | The Author(s) 2021 COPYRIGHT 2021 Springer The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: The Author(s) 2021 – notice: COPYRIGHT 2021 Springer – notice: The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7RV 7T5 7X7 7XB 88E 8AO 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU FYUFA GHDGH H94 K9- K9. KB0 M0R M0S M1P NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM |
| DOI | 10.1007/s00535-021-01769-0 |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Nursing & Allied Health Database Immunology Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials - QC ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts Consumer Health Database ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Consumer Health Database ProQuest Health & Medical Collection Medical Database Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Family Health (Alumni Edition) ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Family Health ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | ProQuest One Academic Middle East (New) CrossRef MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1435-5922 |
| EndPage | 322 |
| ExternalDocumentID | PMC8005399 A714582905 33620586 10_1007_s00535_021_01769_0 |
| Genre | Systematic Review Journal Article Practice Guideline |
| GeographicLocations | Japan |
| GeographicLocations_xml | – name: Japan |
| GroupedDBID | --- -53 -5E -5G -BR -EM -Y2 -~C .55 .86 .GJ .VR 06C 06D 0R~ 0VY 199 1N0 2.D 203 28- 29K 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 36B 3O- 3V. 4.4 406 408 409 40D 40E 53G 5GY 5QI 5VS 67Z 6NX 78A 7RV 7X7 88E 8AO 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAWTL AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACAOD ACBXY ACDTI ACGFS ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACUDM ACZOJ ADBBV ADHIR ADIMF ADINQ ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFEXP AFKRA AFLOW AFQWF AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AOCGG ARMRJ AXYYD AZFZN AZQEC B-. BA0 BBWZM BDATZ BENPR BGNMA BKEYQ BKNYI BPHCQ BSONS BVXVI C6C CAG CCPQU COF CS3 CSCUP D-I DDRTE DL5 DNIVK DPUIP DU5 EBD EBLON EBS EIOEI EJD EMB EMOBN EN4 ESBYG EX3 F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GRRUI GXS H13 HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IAO IHE IHR IJ- IKXTQ IMOTQ INH IWAJR IXC IXD IXE IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ K9- KDC KOV KOW KPH LAS LLZTM M0R M1P M4Y MA- N2Q N9A NAPCQ NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM P19 P2P P9S PCD PF0 PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R89 R9I RHV RIG RNI ROL RPX RRX RSV RZK S16 S1Z S26 S27 S28 S37 S3B SAP SCLPG SDE SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 WOW X7M YLTOR Z45 Z7U Z7W Z82 Z83 Z87 Z8O Z8Q Z8V Z8W Z91 ZMTXR ZOVNA ~EX ~KM AAPKM AAYXX ABBRH ABDBE ABFSG ACSTC ADHKG AEZWR AFDZB AFHIU AFOHR AGQPQ AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM AEIIB PMFND 7T5 7XB 8FK ABRTQ H94 K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 PUEGO 5PM |
| ID | FETCH-LOGICAL-c631t-eb74775241cbce0d2518875736d8435e197754465ee9c0734abe0d28258b8ff3 |
| IEDL.DBID | 7X7 |
| ISSN | 0944-1174 1435-5922 |
| IngestDate | Thu Aug 21 14:37:26 EDT 2025 Fri Sep 05 03:20:47 EDT 2025 Sat Aug 16 17:12:30 EDT 2025 Tue Jun 17 21:55:18 EDT 2025 Tue Jun 10 20:14:42 EDT 2025 Wed Feb 19 02:05:34 EST 2025 Tue Jul 01 04:34:18 EDT 2025 Thu Apr 24 23:00:10 EDT 2025 Fri Feb 21 02:49:33 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Keywords | Peptic ulcer Low-dose aspirin Idiopathic ulcer eradication Nonsteroidal anti-inflammatory drug Helicobacter pylori eradication |
| Language | English |
| License | Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c631t-eb74775241cbce0d2518875736d8435e197754465ee9c0734abe0d28258b8ff3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Instructional Material/Guideline-3 content type line 23 ObjectType-Undefined-4 |
| OpenAccessLink | https://doi.org/10.1007/s00535-021-01769-0 |
| PMID | 33620586 |
| PQID | 2506115699 |
| PQPubID | 33411 |
| PageCount | 20 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_8005399 proquest_miscellaneous_2492660365 proquest_journals_2506115699 gale_infotracmisc_A714582905 gale_infotracacademiconefile_A714582905 pubmed_primary_33620586 crossref_primary_10_1007_s00535_021_01769_0 crossref_citationtrail_10_1007_s00535_021_01769_0 springer_journals_10_1007_s00535_021_01769_0 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2021-04-01 |
| PublicationDateYYYYMMDD | 2021-04-01 |
| PublicationDate_xml | – month: 04 year: 2021 text: 2021-04-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Singapore |
| PublicationPlace_xml | – name: Singapore – name: Japan – name: Tokyo |
| PublicationTitle | Journal of gastroenterology |
| PublicationTitleAbbrev | J Gastroenterol |
| PublicationTitleAlternate | J Gastroenterol |
| PublicationYear | 2021 |
| Publisher | Springer Singapore Springer Springer Nature B.V |
| Publisher_xml | – name: Springer Singapore – name: Springer – name: Springer Nature B.V |
| References | Liou, Bair, Chen (CR28) 2016; 111 Mo, Sun, Wang (CR67) 2015; 10 Furuta, Sugimoto, Kodaira (CR33) 2014; 29 Valgimigli, Bueno, Byrne (CR19) 2018; 39 Sugano, Kinoshita, Miwa (CR53) 2012; 36 Lanas, Wu, Medin (CR71) 2011; 9 Sue, Kuwashima, Iwata (CR31) 2017; 56 Sugimoto, Furuta, Shirai (CR22) 2007; 12 Sakurai, Suda, Ido (CR30) 2017; 23 Lee, Sung, Choi (CR100) 1998; 93 Wong, Lau, Ching (CR97) 2020; 69 Lanza, Chan, Quigley (CR91) 2009; 104 Sugano, Choi, Lin (CR80) 2014; 63 Vergara, Catalan, Gisbert (CR45) 2005; 21 Goldstein, Lowry, Lanza (CR86) 2006; 23 Ray, Chung, Murray (CR20) 2016; 151 Echizen (CR39) 2015; 55 Koch, Deiz, Tarquini (CR51) 2000; 32 Chan, Wong, Suen (CR54) 2007; 369 Chan, To, Wu (CR44) 2002; 359 Mcoll, LE- Nujumi, Chittajallu (CR94) 1993; 34 Laine, Harper, Simon (CR58) 1999; 117 Tunggal, Ng, Lam (CR74) 2011; 162 Selby, Kubba, Hawkey (CR11) 2000; 14 Scally, Emberson, Spata (CR50) 2018; 3 Wong, Wong, Chan (CR96) 2009; 137 Laine, Maller, Yu (CR84) 2004; 127 Masclee, Valkhoff, Coloma (CR55) 2014; 147 Takeuchi, Ota, Harada (CR82) 2014; 29 Nissen, Yeomans, Solomon (CR89) 2016; 375 Di Mario, Battaglia, Leandro (CR35) 1996; 41 Agrawal, Campbell, Safdi (CR42) 2000; 160 Taha, Hudson, Hawkey (CR49) 1996; 334 Goldstein, Cryer, Amer (CR87) 2007; 5 Yano, Tsukahara, Morita (CR72) 2012; 76 Mizokami, Oda, Funao (CR6) 2018; 67 Scheiman, Devereaux, Herlitz (CR83) 2011; 97 Murakami, Furuta, Ando (CR32) 2013; 48 Ren, Zhao, Chen (CR17) 2011; 124 Sugano, Matsumoto, Itabashi (CR77) 2011; 46 Force, MacDonald, Eade (CR108) 1980; 25 Mansour-Ghanaei, Joukar, Naghipour (CR26) 2015; 21 George, George, Androniki (CR13) 2018; 29 Wei, Zhang, Ling (CR18) 2016; 12 Wang, Yang, Cai (CR73) 2013; 24 Chan, Ching, Tse (CR88) 2017; 389 Janke, Stasiewicz, Namiot (CR98) 2000; 47 Iwakiri, Higuchi, Kato (CR79) 2014; 40 Fujimoto, Fujishiro, Kato (CR2) 2014; 26 Ng, Lam, Sung (CR104) 2000; 231 Emery, Zeidler, Kvien (CR57) 1999; 354 Rodríguez-Sanjuán, Fernández-Santiago, García (CR103) 2005; 29 Hawkey, Karrasch, Szczepañski (CR43) 1998; 338 Strand (CR85) 2007; 370 Julka, Aduli, Lamps (CR109) 2008; 100 Kato, Uedo, Hokimoto (CR3) 2018; 30 Chan, Kyaw, Tanigawa (CR68) 2017; 152 Kawai, Oda, Funao (CR7) 2018; 67 Kato, Ota, Okuda (CR21) 2019; 24 Ng, Wong, Lam (CR69) 2010; 138 Poynard, Lemaire, Agostini (CR40) 1995; 7 Hsu, Tsai, Kao (CR27) 2017; 112 Sung, Lau, Ching (CR8) 2010; 152 Kanno, Iijima, Abe (CR95) 2016; 28 Huang, Wang, Wu (CR101) 2004; 51 Yoshida, Kinoshita, Watanabe (CR1) 2015; 50 Murata, Sugimoto, Mizuno (CR25) 2020; 9 Sanuki, Fujita, Kutsumi (CR78) 2012; 47 Ng, Tunggal, Chu (CR70) 2012; 107 Lai, Lam, Chu (CR76) 2002; 346 Jian, Li, Race (CR14) 2016; 82 Tricco, Alateeq, Tashkandi (CR65) 2012; 6 Tsujimae, Yamashita, Hashimura (CR29) 2016; 94 Malfertheiner, Megraud, O'Morain (CR24) 2017; 66 Yuan, Tsoi, Yang (CR63) 2016; 43 Leontiadis, Sharma, Howden (CR12) 2005; 22 Sugimoto, Yamaoka (CR23) 2018; 9 Tang, Ye, Liu (CR46) 2012; 17 Mo, Sun, Lu (CR66) 2015; 21 El-Nakeeb, Fikry, Abd El-Hamed (CR107) 2009; 7 Sugano, Kontani, Katsuo (CR52) 2012; 47 Pavelka, Recker, Verburg (CR59) 2003; 42 Goldstein, Huang, Amer (CR92) 2004; 26 Tunis, Sheinhait, Schmid (CR38) 1997; 19 Koch (CR47) 1999; 31 Vonkeman, Fernandes, van der Palen (CR56) 2007; 9 Taha, McCloskey, Prasad (CR81) 2009; 374 Feng, Ma, Wong (CR62) 2008; 14 Goldstein, Hochberg, Fort (CR93) 2010; 32 Bianchi Porro, Lazzaroni, Petrillo (CR48) 1998; 30 Mcgettigan, Henry (CR90) 2006; 296 Tomtitchong, Siribumrungwong, Vilaichone (CR106) 2012; 17 Leivonene, Haglund, Nordling (CR99) 1997; 9 Bhatt, Cryer, Contant (CR16) 2010; 363 Sakamoto, Kawai, Nakamura (CR60) 2013; 37 Kate, Ananthakrishnan, Badrinath (CR105) 2001; 88 Tarasconi, Baiocchi, Pattonieri (CR9) 2019; 14 Eriksson, Langstrom, Rikner (CR36) 1995; 7 Chan, Chung, Suen (CR75) 2001; 344 Liu, Chen, Lai (CR64) 2012; 107 Wang, Yang, Ma (CR15) 2009; 23 Salas, Ward, Caro (CR37) 2002; 2 Tildesley, Ehsanullah, Wood (CR41) 1993; 32 Mori, Suzuki, Matsuzaki (CR34) 2015; 21 Kyaw, Tse, Ang (CR10) 2014; 2 Murakami, Sakurai, Shiino (CR4) 2016; 65 Miwa, Uedo, Watari (CR5) 2017; 45 Goldstein, Kivitz, Verburg (CR61) 2003; 18 Schilling, Adamek, Wilke (CR102) 1999; 37 T Kanno (1769_CR95) 2016; 28 H Mori (1769_CR34) 2015; 21 SR Tunis (1769_CR38) 1997; 19 JM Liou (1769_CR28) 2016; 111 CP Liu (1769_CR64) 2012; 107 S Sue (1769_CR31) 2017; 56 HE Vonkeman (1769_CR56) 2007; 9 Y Mizokami (1769_CR6) 2018; 67 SE Nissen (1769_CR89) 2016; 375 GS Feng (1769_CR62) 2008; 14 T Poynard (1769_CR40) 1995; 7 T Sanuki (1769_CR78) 2012; 47 AS Taha (1769_CR81) 2009; 374 EK Ng (1769_CR104) 2000; 231 T Takeuchi (1769_CR82) 2014; 29 JL Goldstein (1769_CR92) 2004; 26 T Force (1769_CR108) 1980; 25 YH Ren (1769_CR17) 2011; 124 GI Leontiadis (1769_CR12) 2005; 22 JM Scheiman (1769_CR83) 2011; 97 FH Ng (1769_CR69) 2010; 138 M Valgimigli (1769_CR19) 2018; 39 KC Lai (1769_CR76) 2002; 346 C Mo (1769_CR67) 2015; 10 WH Huang (1769_CR101) 2004; 51 T Kawai (1769_CR7) 2018; 67 CJ Hawkey (1769_CR43) 1998; 338 CL Tang (1769_CR46) 2012; 17 JL Goldstein (1769_CR93) 2010; 32 C Sakamoto (1769_CR60) 2013; 37 YT Lee (1769_CR100) 1998; 93 JC Rodríguez-Sanjuán (1769_CR103) 2005; 29 K Pavelka (1769_CR59) 2003; 42 M Kato (1769_CR3) 2018; 30 K Fujimoto (1769_CR2) 2014; 26 H Yano (1769_CR72) 2012; 76 DL Bhatt (1769_CR16) 2010; 363 S Eriksson (1769_CR36) 1995; 7 A El-Nakeeb (1769_CR107) 2009; 7 M Koch (1769_CR51) 2000; 32 J Wang (1769_CR15) 2009; 23 L Laine (1769_CR58) 1999; 117 M Tsujimae (1769_CR29) 2016; 94 P Malfertheiner (1769_CR24) 2017; 66 FK Chan (1769_CR44) 2002; 359 V Strand (1769_CR85) 2007; 370 G Bianchi Porro (1769_CR48) 1998; 30 FL Lanza (1769_CR91) 2009; 104 KEL Mcoll (1769_CR94) 1993; 34 S George (1769_CR13) 2018; 29 P Emery (1769_CR57) 1999; 354 RN Julka (1769_CR109) 2008; 100 K Sugano (1769_CR53) 2012; 36 K Sugano (1769_CR80) 2014; 63 K Murakami (1769_CR32) 2013; 48 P Tunggal (1769_CR74) 2011; 162 J Goldstein (1769_CR86) 2006; 23 AS Taha (1769_CR49) 1996; 334 R Iwakiri (1769_CR79) 2014; 40 FH Ng (1769_CR70) 2012; 107 NM Selby (1769_CR11) 2000; 14 Z Wang (1769_CR73) 2013; 24 MK Leivonene (1769_CR99) 1997; 9 F Mansour-Ghanaei (1769_CR26) 2015; 21 JJ Sung (1769_CR8) 2010; 152 T Furuta (1769_CR33) 2014; 29 FKL Chan (1769_CR88) 2017; 389 JL Goldstein (1769_CR87) 2007; 5 AC Tricco (1769_CR65) 2012; 6 D Schilling (1769_CR102) 1999; 37 A Lanas (1769_CR71) 2011; 9 A Tarasconi (1769_CR9) 2019; 14 C Mo (1769_CR66) 2015; 21 P Mcgettigan (1769_CR90) 2006; 296 M Sugimoto (1769_CR22) 2007; 12 GL Wong (1769_CR96) 2009; 137 FK Chan (1769_CR54) 2007; 369 F Di Mario (1769_CR35) 1996; 41 M Kyaw (1769_CR10) 2014; 2 WA Ray (1769_CR20) 2016; 151 H Miwa (1769_CR5) 2017; 45 M Salas (1769_CR37) 2002; 2 GLH Wong (1769_CR97) 2020; 69 PI Hsu (1769_CR27) 2017; 112 M Koch (1769_CR47) 1999; 31 K Murakami (1769_CR4) 2016; 65 M Sugimoto (1769_CR23) 2018; 9 V Kate (1769_CR105) 2001; 88 FK Chan (1769_CR75) 2001; 344 K Sugano (1769_CR77) 2011; 46 A Janke (1769_CR98) 2000; 47 P Wei (1769_CR18) 2016; 12 JL Goldstein (1769_CR61) 2003; 18 JQ Yuan (1769_CR63) 2016; 43 M Vergara (1769_CR45) 2005; 21 L Laine (1769_CR84) 2004; 127 M Yoshida (1769_CR1) 2015; 50 K Sakurai (1769_CR30) 2017; 23 M Murata (1769_CR25) 2020; 9 P Tomtitchong (1769_CR106) 2012; 17 B Scally (1769_CR50) 2018; 3 GM Masclee (1769_CR55) 2014; 147 K Sugano (1769_CR52) 2012; 47 NM Agrawal (1769_CR42) 2000; 160 H Echizen (1769_CR39) 2015; 55 Z Jian (1769_CR14) 2016; 82 M Kato (1769_CR21) 2019; 24 FK Chan (1769_CR68) 2017; 152 G Tildesley (1769_CR41) 1993; 32 |
| References_xml | – volume: 112 start-page: 1374 year: 2017 end-page: 1381 ident: CR27 article-title: Ten-day quadruple therapy comprising proton pump inhibitor, bismuth, tetracycline, and levofloxacin is more effective than standard levofloxacin triple therapy in the second-line treatment of infection: a randomized controlled trial publication-title: Am J Gastroenterol – volume: 47 start-page: 1195 year: 2000 end-page: 1198 ident: CR98 article-title: Treatment of gastric stump ulcer: an open study with five drugs publication-title: Hepatogastroenterology – volume: 9 start-page: 762 year: 2011 end-page: 768 ident: CR71 article-title: Low doses of acetylsaiicyiic acid increase risk of gastrointestinal bleeding in a meta-analysis publication-title: Clin Gastroenterol Hepatol – volume: 152 start-page: 1 year: 2010 end-page: 9 ident: CR8 article-title: Continuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trial publication-title: Ann Intern Med – volume: 9 start-page: 543 year: 2020 ident: CR25 article-title: Clarithromycin versus metronidazole in first-line triple eradication therapy based on resistance to antimicrobial agents: meta-analysis publication-title: J Clin Med – volume: 47 start-page: 540 year: 2012 end-page: 552 ident: CR52 article-title: Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term non-steroidal anti-inflammatory drug (NSAID) therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial publication-title: J Gastroenterol – volume: 37 start-page: 346 year: 2013 end-page: 354 ident: CR60 article-title: Comparison of gastroduodenal ulcer incidence in healthy Japanese subjects taking celecoxib or loxoprofen evaluated by endoscopy: a placebo-controlled, double-blind 2-week study publication-title: Aliment Pharmacol Ther – volume: 152 start-page: 105 year: 2017 end-page: 110 ident: CR68 article-title: Similar efficacy of proton-pump inhibitors vs H2-receptor antagonists in reducing risk of upper gastrointestinal bleeding or ulcers in high-risk users of low-dose aspirin publication-title: Gastroenterology – volume: 36 start-page: 115 year: 2012 end-page: 125 ident: CR53 article-title: Randomised clinical trial: esomeprazole for the prevention of nonsteroidal anti-inflammatory drug-related peptic ulcers in Japanese patients publication-title: Aliment Pharmacol Ther. – volume: 369 start-page: 1621 year: 2007 end-page: 1626 ident: CR54 article-title: Combination of a cyclooxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial publication-title: Lancet – volume: 375 start-page: 2519 year: 2016 end-page: 2529 ident: CR89 article-title: Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis publication-title: N Engl J Med – volume: 107 start-page: 1022 year: 2012 end-page: 1029 ident: CR64 article-title: Esomeprazole alone compared with esomeprazole plus aspirin for the treatment of aspirin-related peptic ulcers publication-title: Am J Gastroenterol – volume: 48 start-page: 1128 year: 2013 end-page: 1135 ident: CR32 article-title: Multi-center randomized controlled study to establish the standard third-line regimen for eradication in Japan publication-title: J Gastroenterol – volume: 22 start-page: 169 year: 2005 end-page: 174 ident: CR12 article-title: Systematic review and meta-analysis: proton-pump inhibitor treatment for ulcer bleeding reduces transfusion requirements and hospital stay-results from the Cochrane Collaboration publication-title: Aliment Pharmacol Ther – volume: 56 start-page: 1277 year: 2017 end-page: 1285 ident: CR31 article-title: The superiority of vonoprazan-based first-line triple therapy with clarithromycin: a prospective multi-center cohort study on eradication publication-title: Intern Med – volume: 160 start-page: 1455 year: 2000 end-page: 1461 ident: CR42 article-title: Superiority of lansoprazole vs ranitidine in healing nonsteroidal anti-inflammatory drug-associated gastric ulcers: results of a double-blind, randomized, multicenter study publication-title: Arch Intern Med. – volume: 32 start-page: 474 year: 1993 end-page: 478 ident: CR41 article-title: Ranitidine in the treatment of gastric and duodenal ulcers associated with non-steroidal anti-inflammatory drugs publication-title: Br J Rheumatol – volume: 51 start-page: 1551 year: 2004 end-page: 1553 ident: CR101 article-title: infection in patients with ulcer recurrence after partial gastrectomy publication-title: Hepatogastroenterology – volume: 88 start-page: 1054 year: 2001 end-page: 1058 ident: CR105 article-title: Effect of eradication on the ulcer recurrence rate after simple closure of perforated duodenal ulcer: retrospective and prospective randomized controlled studies publication-title: Br J Surg – volume: 31 start-page: S54 issue: Suppl 1 year: 1999 end-page: 62 ident: CR47 article-title: Non-steroidal anti-inflammatory drug gastropathy: clinical results with misoprostol publication-title: Ital J Gastroenterol Hepatol – volume: 65 start-page: 1439 year: 2016 end-page: 1446 ident: CR4 article-title: Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for eradication: a phase III, randomised, double-blind study publication-title: Gut – volume: 32 start-page: 138 year: 2000 end-page: 151 ident: CR51 article-title: Prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal mucosal injury: risk factors for serious complications publication-title: Digest Liver Dis – volume: 5 start-page: 1167 year: 2007 end-page: 1174 ident: CR87 article-title: Celecoxib plus aspirin versus naproxen and lansoprazole plus aspirin: a randomized, double-blind, endoscopic trial publication-title: Clin Gastroenterol Hepatol – volume: 7 start-page: 661 year: 1995 end-page: 665 ident: CR40 article-title: Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer publication-title: Eur J Gastroenterol Hepatol – volume: 39 start-page: 213 year: 2018 end-page: 260 ident: CR19 article-title: 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS) publication-title: Eur Heart J – volume: 2 start-page: 17 year: 2002 ident: CR37 article-title: Are proton pump inhibitors the first choice for acute treatment of gastric ulcers? A meta-analysis of randomized clinical trials publication-title: BMC Gastroenterol – volume: 9 start-page: 371 year: 1997 end-page: 374 ident: CR99 article-title: infection after partial gastrectomy for peptic ulcer and its role in relapsing disease publication-title: Eur J Gastroenterol Hepatol – volume: 93 start-page: 928 year: 1998 end-page: 931 ident: CR100 article-title: Ulcer recurrence after gastric surgery: is the culprit? publication-title: Am J Gastroenterol – volume: 55 start-page: 409 year: 2015 end-page: 418 ident: CR39 article-title: The first-in-class potassium-competitive acid blocker, vonoprazan fumarate: pharmacokinetic and pharmacodynamic considerations publication-title: Clin Pharmacokinet – volume: 97 start-page: 797 year: 2011 end-page: 802 ident: CR83 article-title: Prevention of peptic ulcers with esomeprazole in patients at risk of ulcer development treated with low-dose acetylsalicylic acid: a randomised, controlled trial (OBERON) publication-title: Heart – volume: 12 start-page: 2861 year: 2016 end-page: 2864 ident: CR18 article-title: Effects of the short-term application of pantoprazole combined with aspirin and clopidogrel in the treatment of acute STEMI publication-title: Exp Ther Med – volume: 354 start-page: 2106 year: 1999 end-page: 2111 ident: CR57 article-title: Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomized double-blind comparison publication-title: Lancet – volume: 363 start-page: 1909 year: 2010 end-page: 1917 ident: CR16 article-title: Clopidogrel with or without omeprazole in coronary artery disease publication-title: N Engl J Med – volume: 389 start-page: 2375 year: 2017 end-page: 2382 ident: CR88 article-title: Gastrointestinal safety of celecoxib versus naproxen in patients with cardiothrombotic diseases and arthritis after upper gastrointestinal bleeding (CONCERN): an industry-independent, double-blind, double-dummy, randomised trial publication-title: Lancet – volume: 2 start-page: E6 year: 2014 end-page: 14 ident: CR10 article-title: Embolization versus surgery for peptic ulcer bleeding after failed endoscopic hemostasis: a meta-analysis publication-title: Endos Int Open – volume: 231 start-page: 153 year: 2000 end-page: 158 ident: CR104 article-title: Eradication of prevents recurrence of ulcer after simple closure of duodenal ulcer perforation: randomized controlled trial publication-title: Ann Surg – volume: 100 start-page: 339 year: 2008 end-page: 341 ident: CR109 article-title: Ischemic duodenal ulcer, an unusual presentation of sickle cell disease publication-title: J Natl Med Assoc – volume: 50 start-page: 4 year: 2015 end-page: 10 ident: CR1 article-title: JSGE clinical practice guideline 2014: standards, methods, and process of developing guidelines publication-title: J Gastroenterol – volume: 162 start-page: 870 year: 2011 end-page: 874 ident: CR74 article-title: Effect of esomeprazole versus famotidine on platelet inhibition by clopidogrel: a double-blind, randomized trial publication-title: Am Heart J – volume: 29 start-page: 22 year: 2018 end-page: 31 ident: CR13 article-title: High-dose vs. low-dose proton pump inhibitors post endoscopic hemostasis in patients with bleeding peptic ulcer: a meta-analysis and meta-regression analysis publication-title: Turk J Gastroenterol – volume: 338 start-page: 727 year: 1998 end-page: 734 ident: CR43 article-title: Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs publication-title: N Engl J Med – volume: 24 start-page: 453 year: 2013 end-page: 457 ident: CR73 article-title: Influence of different proton pump inhibitors on platelet function in acute myocardial infarction patients receiving clopidogrel treatment after percutaneous coronary intervention publication-title: Biomed Res – volume: 334 start-page: 1435 year: 1996 end-page: 1439 ident: CR49 article-title: Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs publication-title: N Engl J Med – volume: 26 start-page: 1637 year: 2004 end-page: 1643 ident: CR92 article-title: Ulcer recurrence in high-risk patients receiving nonsteroidal anti-inflammatory drugs plus low-dose aspirin: results of a post Hoc subanalysis publication-title: Clin Ther – volume: 147 start-page: 784 year: 2014 end-page: 792 ident: CR55 article-title: Risk of upper gastrointestinal bleeding from different drug combinations publication-title: Gastroenterology – volume: 34 start-page: 762 year: 1993 end-page: 768 ident: CR94 article-title: A study of the pathogenesis of negative chronic duodenal ulceration publication-title: Gut – volume: 32 start-page: 401 year: 2010 end-page: 413 ident: CR93 article-title: Clinical trial: the incidence of NSAID-associated endoscopic gastric ulcers in patients treated with PN 400 (naproxen plus esomeprazole magnesium) vs. enteric-coated naproxen alone publication-title: Aliment Pharmacol Ther. – volume: 137 start-page: 525 year: 2009 end-page: 531 ident: CR96 article-title: High incidence of mortality and recurrent bleeding in patients with -negative idiopathic bleeding ulcers publication-title: Gastroenterology – volume: 104 start-page: 728 year: 2009 end-page: 738 ident: CR91 article-title: Guidelines for prevention of NSAID-related ulcer complications publication-title: Am J Gastroenterol – volume: 37 start-page: 127 year: 1999 end-page: 132 ident: CR102 article-title: Prevalence and clinical importance of infection in patients after partial gastric resection for peptic ulcer disease publication-title: Z Gastroenterol – volume: 370 start-page: 2138 year: 2007 end-page: 2151 ident: CR85 article-title: Are COX-2 inhibitors preferable to non-selective non-steroidal anti-inflammatory drugs in patients with risk of cardiovascular events taking low-dose aspirin publication-title: Lancet – volume: 69 start-page: 652 year: 2020 end-page: 657 ident: CR97 article-title: Prevention of recurrent idiopathic gastroduodenal ulcer bleeding: a double-blind, randomised trial publication-title: Gut – volume: 46 start-page: 724 year: 2011 end-page: 725 ident: CR77 article-title: Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term low-dose aspirin therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial publication-title: J Gastroenterol – volume: 28 start-page: 556 year: 2016 end-page: 563 ident: CR95 article-title: -negative and non-steroidal anti-inflammatory drugs-negative idiopathic peptic ulcers show refractoriness and high recurrence incidence: multicenter follow-up study of peptic ulcers in Japan publication-title: Dig Endosc – volume: 43 start-page: 1262 year: 2016 end-page: 1275 ident: CR63 article-title: Systematic review with network meta-analysis: comparative effectiveness and safety of strategies for preventing NSAID-associated gastrointestinal toxicity publication-title: Aliment Pharmacol Ther – volume: 29 start-page: 849 year: 2005 end-page: 852 ident: CR103 article-title: Perforated peptic ulcer treated by simple closure and eradication publication-title: World J Surg – volume: 14 start-page: 1119 year: 2000 end-page: 1126 ident: CR11 article-title: Acid suppression in peptic ulcer haemorrhage: a ‘meta-analysis’ publication-title: Aliment Pharmacol Ther – volume: 76 start-page: 2673 year: 2012 end-page: 2680 ident: CR72 article-title: Influence of omeprazole and famotidine on the antiplatelet effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes: a prospective, randomized, multicenter study publication-title: Circ J – volume: 9 start-page: R52 year: 2007 ident: CR56 article-title: Proton-pump inhibitors are associated with a reduced risk for bleeding and perforated gastroduodenal ulcers attributable to non-steroidal anti-inflammatory drugs: a nested case-control study publication-title: Arthritis Res Ther – volume: 21 start-page: 5382 year: 2015 end-page: 5392 ident: CR66 article-title: Proton pump inhibitors in prevention of low-dose aspirin-associated upper gastrointestinal injuries publication-title: World J Gastroenterol – volume: 374 start-page: 119 year: 2009 end-page: 125 ident: CR81 article-title: Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial publication-title: Lancet – volume: 296 start-page: 1633 year: 2006 end-page: 1644 ident: CR90 article-title: Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2 publication-title: JAMA – volume: 66 start-page: 6 year: 2017 end-page: 30 ident: CR24 article-title: Management of infection-the Maastricht V/Florence Consensus Report publication-title: Gut – volume: 41 start-page: 1108 year: 1996 end-page: 1131 ident: CR35 article-title: Short-term treatment of gastric ulcer: a meta-analytical evaluation of blind trials publication-title: Dig Dis Sci – volume: 63 start-page: 1061 year: 2014 end-page: 1068 ident: CR80 article-title: Multinational, double-blind, randomised, placebo-controlled, prospective study of esomeprazole in the prevention of recurrent peptic ulcer in low-dose acetylsalicylic acid users: the LAVENDER study publication-title: Gut – volume: 3 start-page: 231 year: 2018 end-page: 241 ident: CR50 article-title: Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: a meta-analysis of randomised trials publication-title: Lancet Gastroenterol Hepatol – volume: 30 start-page: 43 year: 1998 end-page: 47 ident: CR48 article-title: Prevention of gastroduodenal damage with omeprazole in patients receiving continuous NSAIDs treatment: a double blind placebo controlled study publication-title: Ital J Gastroenterol Hepatol – volume: 19 start-page: 743 year: 1997 end-page: 757 ident: CR38 article-title: Lansoprazole compared with histamine 2-receptor antagonists in healing gastric ulcers: a meta-analysis publication-title: Clin Ther – volume: 30 start-page: 433 year: 2018 end-page: 440 ident: CR3 article-title: Guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatment: 2017 appendix on anticoagulants including direct oral anticoagulants publication-title: Dig Endosc – volume: 18 start-page: 125 year: 2003 end-page: 132 ident: CR61 article-title: A comparison of the upper gastrointestinal mucosal effects of valdecoxib, naproxen and placebo in healthy elderly subjects publication-title: Aliment Pharmacol Ther – volume: 17 start-page: 148 year: 2012 end-page: 152 ident: CR106 article-title: Systematic review and meta-analysis: eradication therapy after simple closure of perforated duodenal ulcer publication-title: Helicobacter – volume: 17 start-page: 286 year: 2012 end-page: 296 ident: CR46 article-title: Eradication of infection reduces the incidence of peptic ulcer disease in patients using nonsteroidal anti-inflammatory drugs: a meta-analysis publication-title: Helicobacter – volume: 67 start-page: 1033 year: 2018 end-page: 1041 ident: CR7 article-title: Vonoprazan prevents low-dose aspirin-associated ulcer recurrence: randomised phase 3 study publication-title: Gut – volume: 111 start-page: 381 year: 2016 end-page: 387 ident: CR28 article-title: Levofloxacin sequential therapy vs levofloxacin triple therapy in the second-line treatment of : a randomized trial publication-title: Am J Gastroenterol – volume: 21 start-page: 286 year: 2015 end-page: 294 ident: CR34 article-title: Efficacy of 10-day sitafloxacin-containing third-line therapies for strains containing the gyrA mutation publication-title: Helicobacter – volume: 14 start-page: 3 year: 2019 ident: CR9 article-title: Transcatheter arterial embolization versus surgery for refractory non-variceal upper gastrointestinal bleeding: a meta-analysis publication-title: World J Emerg Surg – volume: 29 start-page: 11 issue: Suppl. 4 year: 2014 end-page: 15 ident: CR82 article-title: Comparison of teprenone and famotidine against gastroduodenal mucosal damage in patients taking low-dose aspirin publication-title: J Gastroenterol Hepatol – volume: 26 start-page: 1 year: 2014 end-page: 14 ident: CR2 article-title: Guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatment publication-title: Dig Endosc – volume: 6 start-page: e109 year: 2012 end-page: e117 ident: CR65 article-title: Histamine H2 receptor antagonists for decreasing gastrointestinal harms in adults using acetylsalicylic acid: systematic review and meta-analysis publication-title: Open Med – volume: 10 start-page: e0131558 year: 2015 ident: CR67 article-title: PPI versus histamine H2 receptor antagonists for prevention of upper gastrointestinal injury associated with low-dose aspirin: Systematic review and meta-analysis publication-title: PLoS ONE – volume: 346 start-page: 2033 year: 2002 end-page: 2038 ident: CR76 article-title: Lansoprazole for the prevention of recurrence of ulcer complications from long-term low-dose aspirin use publication-title: N Engl J Med – volume: 47 start-page: 1186 year: 2012 end-page: 1197 ident: CR78 article-title: Rabeprazole reduces the recurrence risk of peptic ulcers associated with low-dose aspirin in patients with cardiovascular or cerebrovascular disease: a prospective randomized active-controlled trial publication-title: J Gastroenterol – volume: 14 start-page: 4535 year: 2008 end-page: 4539 ident: CR62 article-title: Celecoxib-related gastroduodenal ulcer and cardiovascular events in a randomized trial for gastric cancer prevention publication-title: World J Gastroenterol – volume: 21 start-page: 1411 year: 2005 end-page: 1418 ident: CR45 article-title: Meta-analysis: role of eradication in the prevention of peptic ulcer in NSAID users publication-title: Aliment Pharmacol Ther – volume: 124 start-page: 856 year: 2011 end-page: 861 ident: CR17 article-title: Omeprazole affects clopidogrel efficacy but not ischemic events in patients with acute coronary syndrome undergoing elective percutaneous coronary intervention publication-title: Chin Med J – volume: 45 start-page: 240 year: 2017 end-page: 252 ident: CR5 article-title: Randomised clinical trial: efficacy and safety of vonoprazan vs. lansoprazole in patients with gastric or duodenal ulcers-results from two phase 3, non-inferiority randomised controlled trials publication-title: Aliment Pharmacol Ther – volume: 7 start-page: 467 year: 1995 end-page: 475 ident: CR36 article-title: Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis publication-title: Eur J Gastroenterol Hepatol – volume: 21 start-page: 661 year: 2015 end-page: 666 ident: CR26 article-title: Seven-day quintuple regimen as a rescue therapy for eradication publication-title: World J Gastroenterol – volume: 117 start-page: 776 year: 1999 end-page: 783 ident: CR58 article-title: A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis: Rofecoxib Osteoarthritis Endoscopy Study Group publication-title: Gastroenterology – volume: 67 start-page: 1042 year: 2018 end-page: 1051 ident: CR6 article-title: Vonoprazan prevents ulcer recurrence during long-term NSAID therapy: randomised, lansoprazole-controlled non-inferiority and single-blind extension study publication-title: Gut – volume: 359 start-page: 9 year: 2002 end-page: 13 ident: CR44 article-title: Eradication of and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial publication-title: Lancet – volume: 42 start-page: 1207 year: 2003 end-page: 1215 ident: CR59 article-title: Valdecoxib is as effective as diclofenac in the management of rheumatoid arthritis with a lower incidence of gastroduodenal ulcers: results of a 26-week trial publication-title: Rheumatology – volume: 24 start-page: e12597 year: 2019 ident: CR21 article-title: Guidelines for the management of infection in Japan: 2016 Revised Edition publication-title: Helicobacter – volume: 82 start-page: 880 year: 2016 end-page: 889 ident: CR14 article-title: Is the era of intravenous proton pump inhibitors coming to an end in patients with bleeding peptic ulcers? Meta-analysis of the published literature publication-title: Br J Clin Pharmacol – volume: 94 start-page: 240 year: 2016 end-page: 246 ident: CR29 article-title: A comparative study of a new class of gastric acid suppressant agent named vonoparazan versus esomeprazole for the eradication of publication-title: Digestion – volume: 23 start-page: 1489 year: 2006 end-page: 1498 ident: CR86 article-title: The impact of low-dose aspirin on endoscopic gastric and duodenal ulcer rates in users of a non-selective non-steroidal anti-inflammatory drug or a cyclo-oxygenase-2-selective inhibitor publication-title: Aliment Pharmacol Ther – volume: 12 start-page: 317 year: 2007 end-page: 323 ident: CR22 article-title: Evidence that the degree and duration of acid suppression are related to eradication by triple therapy publication-title: Helicobacter – volume: 23 start-page: 668 year: 2017 end-page: 675 ident: CR30 article-title: Comparative study: Vonoprazan and proton pump inhibitors in eradication therapy publication-title: World J Gastroenterol – volume: 40 start-page: 780 year: 2014 end-page: 795 ident: CR79 article-title: Randomised clinical trial: prevention of recurrence of peptic ulcers by rabeprazole in patients taking low-dose aspirin publication-title: Aliment Pharmacol Ther – volume: 23 start-page: 287 year: 2009 end-page: 299 ident: CR15 article-title: Intravenous pantoprazole as an adjuvant therapy following successful endoscopic treatment for peptic ulcer bleeding publication-title: Can J Gastroenterol – volume: 9 start-page: 1560 year: 2018 ident: CR23 article-title: Role of vonoprazan in eradication therapy in Japan publication-title: Front Pharmacol – volume: 107 start-page: 389 year: 2012 end-page: 396 ident: CR70 article-title: Esomeprazole compared with famotidine in the prevention of upper gastrointestinal bleeding in patients with acute coronary syndrome or myocardial infarction publication-title: Am J Gastroenterol – volume: 344 start-page: 967 year: 2001 end-page: 973 ident: CR75 article-title: Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen publication-title: N Engl J Med – volume: 7 start-page: 126 year: 2009 end-page: 129 ident: CR107 article-title: Effect of eradication on ulcer recurrence after simple closure of perforated duodenal ulcer publication-title: Int J Surg – volume: 25 start-page: 307 year: 1980 end-page: 310 ident: CR108 article-title: Ischemic gastritis and duodenitis publication-title: Dig Dis Sci – volume: 151 start-page: 1105 year: 2016 end-page: 1112 ident: CR20 article-title: Association of proton pump inhibitors with reduced risk of warfarin-related serious upper gastrointestinal bleeding publication-title: Gastroenterology – volume: 29 start-page: 487 year: 2014 end-page: 493 ident: CR33 article-title: Sitafloxacin-based third-line rescue regimens for infection in Japan publication-title: J Gastroenterol Hepatol – volume: 127 start-page: 395 year: 2004 end-page: 402 ident: CR84 article-title: Ulcer formation with low-dose enteric-coated aspirin and the effect of COX-2 selective inhibition: a double-blind trial publication-title: Gastroenterology – volume: 138 start-page: 82 year: 2010 end-page: 88 ident: CR69 article-title: Famotidine is inferior to pantoprazole in preventing recurrence of aspirin-related peptic ulcers or erosions publication-title: Gastroenterology – volume: 24 start-page: 453 year: 2013 ident: 1769_CR73 publication-title: Biomed Res – volume: 23 start-page: 1489 year: 2006 ident: 1769_CR86 publication-title: Aliment Pharmacol Ther doi: 10.1111/j.1365-2036.2006.02912.x – volume: 152 start-page: 105 year: 2017 ident: 1769_CR68 publication-title: Gastroenterology doi: 10.1053/j.gastro.2016.09.006 – volume: 23 start-page: 668 year: 2017 ident: 1769_CR30 publication-title: World J Gastroenterol doi: 10.3748/wjg.v23.i4.668 – volume: 65 start-page: 1439 year: 2016 ident: 1769_CR4 publication-title: Gut doi: 10.1136/gutjnl-2015-311304 – volume: 47 start-page: 540 year: 2012 ident: 1769_CR52 publication-title: J Gastroenterol doi: 10.1007/s00535-012-0541-z – volume: 37 start-page: 346 year: 2013 ident: 1769_CR60 publication-title: Aliment Pharmacol Ther doi: 10.1111/apt.12174 – volume: 138 start-page: 82 year: 2010 ident: 1769_CR69 publication-title: Gastroenterology doi: 10.1053/j.gastro.2009.09.063 – volume: 370 start-page: 2138 year: 2007 ident: 1769_CR85 publication-title: Lancet doi: 10.1016/S0140-6736(07)61909-6 – volume: 26 start-page: 1637 year: 2004 ident: 1769_CR92 publication-title: Clin Ther doi: 10.1016/j.clinthera.2004.10.002 – volume: 32 start-page: 474 year: 1993 ident: 1769_CR41 publication-title: Br J Rheumatol doi: 10.1093/rheumatology/32.6.474 – volume: 354 start-page: 2106 year: 1999 ident: 1769_CR57 publication-title: Lancet doi: 10.1016/S0140-6736(99)02332-6 – volume: 107 start-page: 1022 year: 2012 ident: 1769_CR64 publication-title: Am J Gastroenterol doi: 10.1038/ajg.2012.87 – volume: 21 start-page: 5382 year: 2015 ident: 1769_CR66 publication-title: World J Gastroenterol doi: 10.3748/wjg.v21.i17.5382 – volume: 10 start-page: e0131558 year: 2015 ident: 1769_CR67 publication-title: PLoS ONE doi: 10.1371/journal.pone.0131558 – volume: 19 start-page: 743 year: 1997 ident: 1769_CR38 publication-title: Clin Ther doi: 10.1016/S0149-2918(97)80098-7 – volume: 46 start-page: 724 year: 2011 ident: 1769_CR77 publication-title: J Gastroenterol doi: 10.1007/s00535-011-0397-7 – volume: 23 start-page: 287 year: 2009 ident: 1769_CR15 publication-title: Can J Gastroenterol doi: 10.1155/2009/191706 – volume: 359 start-page: 9 year: 2002 ident: 1769_CR44 publication-title: Lancet doi: 10.1016/S0140-6736(02)07272-0 – volume: 137 start-page: 525 year: 2009 ident: 1769_CR96 publication-title: Gastroenterology doi: 10.1053/j.gastro.2009.05.006 – volume: 39 start-page: 213 year: 2018 ident: 1769_CR19 publication-title: Eur Heart J doi: 10.1093/eurheartj/ehx419 – volume: 47 start-page: 1195 year: 2000 ident: 1769_CR98 publication-title: Hepatogastroenterology – volume: 127 start-page: 395 year: 2004 ident: 1769_CR84 publication-title: Gastroenterology doi: 10.1053/j.gastro.2004.05.001 – volume: 6 start-page: e109 year: 2012 ident: 1769_CR65 publication-title: Open Med – volume: 97 start-page: 797 year: 2011 ident: 1769_CR83 publication-title: Heart doi: 10.1136/hrt.2010.217547 – volume: 69 start-page: 652 year: 2020 ident: 1769_CR97 publication-title: Gut doi: 10.1136/gutjnl-2019-318715 – volume: 29 start-page: 487 year: 2014 ident: 1769_CR33 publication-title: J Gastroenterol Hepatol doi: 10.1111/jgh.12442 – volume: 296 start-page: 1633 year: 2006 ident: 1769_CR90 publication-title: JAMA doi: 10.1001/jama.296.13.jrv60011 – volume: 21 start-page: 286 year: 2015 ident: 1769_CR34 publication-title: Helicobacter doi: 10.1111/hel.12286 – volume: 42 start-page: 1207 year: 2003 ident: 1769_CR59 publication-title: Rheumatology doi: 10.1093/rheumatology/keg359 – volume: 346 start-page: 2033 year: 2002 ident: 1769_CR76 publication-title: N Engl J Med doi: 10.1056/NEJMoa012877 – volume: 17 start-page: 148 year: 2012 ident: 1769_CR106 publication-title: Helicobacter doi: 10.1111/j.1523-5378.2011.00928.x – volume: 14 start-page: 1119 year: 2000 ident: 1769_CR11 publication-title: Aliment Pharmacol Ther doi: 10.1046/j.1365-2036.2000.00822.x – volume: 14 start-page: 4535 year: 2008 ident: 1769_CR62 publication-title: World J Gastroenterol doi: 10.3748/wjg.14.4535 – volume: 7 start-page: 661 year: 1995 ident: 1769_CR40 publication-title: Eur J Gastroenterol Hepatol – volume: 30 start-page: 43 year: 1998 ident: 1769_CR48 publication-title: Ital J Gastroenterol Hepatol – volume: 32 start-page: 138 year: 2000 ident: 1769_CR51 publication-title: Digest Liver Dis doi: 10.1016/S1590-8658(00)80402-8 – volume: 344 start-page: 967 year: 2001 ident: 1769_CR75 publication-title: N Engl J Med doi: 10.1056/NEJM200103293441304 – volume: 32 start-page: 401 year: 2010 ident: 1769_CR93 publication-title: Aliment Pharmacol Ther. doi: 10.1111/j.1365-2036.2010.04378.x – volume: 152 start-page: 1 year: 2010 ident: 1769_CR8 publication-title: Ann Intern Med doi: 10.7326/0003-4819-152-1-201001050-00179 – volume: 63 start-page: 1061 year: 2014 ident: 1769_CR80 publication-title: Gut doi: 10.1136/gutjnl-2013-304722 – volume: 41 start-page: 1108 year: 1996 ident: 1769_CR35 publication-title: Dig Dis Sci doi: 10.1007/BF02088227 – volume: 117 start-page: 776 year: 1999 ident: 1769_CR58 publication-title: Gastroenterology doi: 10.1016/S0016-5085(99)70334-3 – volume: 9 start-page: 1560 year: 2018 ident: 1769_CR23 publication-title: Front Pharmacol doi: 10.3389/fphar.2018.01560 – volume: 2 start-page: E6 year: 2014 ident: 1769_CR10 publication-title: Endos Int Open doi: 10.1055/s-0034-1365235 – volume: 124 start-page: 856 year: 2011 ident: 1769_CR17 publication-title: Chin Med J – volume: 389 start-page: 2375 year: 2017 ident: 1769_CR88 publication-title: Lancet doi: 10.1016/S0140-6736(17)30981-9 – volume: 66 start-page: 6 year: 2017 ident: 1769_CR24 publication-title: Gut doi: 10.1136/gutjnl-2016-312288 – volume: 29 start-page: 849 year: 2005 ident: 1769_CR103 publication-title: World J Surg doi: 10.1007/s00268-005-7797-x – volume: 29 start-page: 11 issue: Suppl. 4 year: 2014 ident: 1769_CR82 publication-title: J Gastroenterol Hepatol doi: 10.1111/jgh.12768 – volume: 29 start-page: 22 year: 2018 ident: 1769_CR13 publication-title: Turk J Gastroenterol doi: 10.5152/tjg.2018.17143 – volume: 9 start-page: 543 year: 2020 ident: 1769_CR25 publication-title: J Clin Med doi: 10.3390/jcm9020543 – volume: 47 start-page: 1186 year: 2012 ident: 1769_CR78 publication-title: J Gastroenterol doi: 10.1007/s00535-012-0588-x – volume: 30 start-page: 433 year: 2018 ident: 1769_CR3 publication-title: Dig Endosc doi: 10.1111/den.13184 – volume: 18 start-page: 125 year: 2003 ident: 1769_CR61 publication-title: Aliment Pharmacol Ther doi: 10.1046/j.1365-2036.2003.01650.x – volume: 94 start-page: 240 year: 2016 ident: 1769_CR29 publication-title: Digestion doi: 10.1159/000454762 – volume: 162 start-page: 870 year: 2011 ident: 1769_CR74 publication-title: Am Heart J doi: 10.1016/j.ahj.2011.08.007 – volume: 82 start-page: 880 year: 2016 ident: 1769_CR14 publication-title: Br J Clin Pharmacol doi: 10.1111/bcp.12866 – volume: 2 start-page: 17 year: 2002 ident: 1769_CR37 publication-title: BMC Gastroenterol doi: 10.1186/1471-230X-2-17 – volume: 374 start-page: 119 year: 2009 ident: 1769_CR81 publication-title: Lancet doi: 10.1016/S0140-6736(09)61246-0 – volume: 50 start-page: 4 year: 2015 ident: 1769_CR1 publication-title: J Gastroenterol doi: 10.1007/s00535-014-1016-1 – volume: 22 start-page: 169 year: 2005 ident: 1769_CR12 publication-title: Aliment Pharmacol Ther doi: 10.1111/j.1365-2036.2005.02546.x – volume: 48 start-page: 1128 year: 2013 ident: 1769_CR32 publication-title: J Gastroenterol doi: 10.1007/s00535-012-0731-8 – volume: 5 start-page: 1167 year: 2007 ident: 1769_CR87 publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2007.06.009 – volume: 104 start-page: 728 year: 2009 ident: 1769_CR91 publication-title: Am J Gastroenterol – volume: 107 start-page: 389 year: 2012 ident: 1769_CR70 publication-title: Am J Gastroenterol doi: 10.1038/ajg.2011.385 – volume: 111 start-page: 381 year: 2016 ident: 1769_CR28 publication-title: Am J Gastroenterol doi: 10.1038/ajg.2015.439 – volume: 55 start-page: 409 year: 2015 ident: 1769_CR39 publication-title: Clin Pharmacokinet doi: 10.1007/s40262-015-0326-7 – volume: 100 start-page: 339 year: 2008 ident: 1769_CR109 publication-title: J Natl Med Assoc – volume: 231 start-page: 153 year: 2000 ident: 1769_CR104 publication-title: Ann Surg doi: 10.1097/00000658-200002000-00001 – volume: 9 start-page: 762 year: 2011 ident: 1769_CR71 publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2011.05.020 – volume: 7 start-page: 467 year: 1995 ident: 1769_CR36 publication-title: Eur J Gastroenterol Hepatol – volume: 21 start-page: 661 year: 2015 ident: 1769_CR26 publication-title: World J Gastroenterol doi: 10.3748/wjg.v21.i2.661 – volume: 14 start-page: 3 year: 2019 ident: 1769_CR9 publication-title: World J Emerg Surg doi: 10.1186/s13017-019-0223-8 – volume: 56 start-page: 1277 year: 2017 ident: 1769_CR31 publication-title: Intern Med doi: 10.2169/internalmedicine.56.7833 – volume: 76 start-page: 2673 year: 2012 ident: 1769_CR72 publication-title: Circ J doi: 10.1253/circj.CJ-12-0511 – volume: 93 start-page: 928 year: 1998 ident: 1769_CR100 publication-title: Am J Gastroenterol doi: 10.1111/j.1572-0241.1998.00279.x – volume: 24 start-page: e12597 year: 2019 ident: 1769_CR21 publication-title: Helicobacter doi: 10.1111/hel.12597 – volume: 7 start-page: 126 year: 2009 ident: 1769_CR107 publication-title: Int J Surg doi: 10.1016/j.ijsu.2008.12.001 – volume: 12 start-page: 2861 year: 2016 ident: 1769_CR18 publication-title: Exp Ther Med doi: 10.3892/etm.2016.3693 – volume: 112 start-page: 1374 year: 2017 ident: 1769_CR27 publication-title: Am J Gastroenterol doi: 10.1038/ajg.2017.195 – volume: 43 start-page: 1262 year: 2016 ident: 1769_CR63 publication-title: Aliment Pharmacol Ther doi: 10.1111/apt.13642 – volume: 375 start-page: 2519 year: 2016 ident: 1769_CR89 publication-title: N Engl J Med doi: 10.1056/NEJMoa1611593 – volume: 51 start-page: 1551 year: 2004 ident: 1769_CR101 publication-title: Hepatogastroenterology – volume: 45 start-page: 240 year: 2017 ident: 1769_CR5 publication-title: Aliment Pharmacol Ther doi: 10.1111/apt.13876 – volume: 37 start-page: 127 year: 1999 ident: 1769_CR102 publication-title: Z Gastroenterol – volume: 36 start-page: 115 year: 2012 ident: 1769_CR53 publication-title: Aliment Pharmacol Ther. doi: 10.1111/j.1365-2036.2012.05133.x – volume: 147 start-page: 784 year: 2014 ident: 1769_CR55 publication-title: Gastroenterology doi: 10.1053/j.gastro.2014.06.007 – volume: 25 start-page: 307 year: 1980 ident: 1769_CR108 publication-title: Dig Dis Sci doi: 10.1007/BF01308523 – volume: 9 start-page: R52 year: 2007 ident: 1769_CR56 publication-title: Arthritis Res Ther doi: 10.1186/ar2207 – volume: 363 start-page: 1909 year: 2010 ident: 1769_CR16 publication-title: N Engl J Med doi: 10.1056/NEJMoa1007964 – volume: 9 start-page: 371 year: 1997 ident: 1769_CR99 publication-title: Eur J Gastroenterol Hepatol – volume: 21 start-page: 1411 year: 2005 ident: 1769_CR45 publication-title: Aliment Pharmacol Ther doi: 10.1111/j.1365-2036.2005.02444.x – volume: 369 start-page: 1621 year: 2007 ident: 1769_CR54 publication-title: Lancet doi: 10.1016/S0140-6736(07)60749-1 – volume: 338 start-page: 727 year: 1998 ident: 1769_CR43 publication-title: N Engl J Med doi: 10.1056/NEJM199803123381105 – volume: 28 start-page: 556 year: 2016 ident: 1769_CR95 publication-title: Dig Endosc doi: 10.1111/den.12635 – volume: 67 start-page: 1042 year: 2018 ident: 1769_CR6 publication-title: Gut doi: 10.1136/gutjnl-2017-314010 – volume: 160 start-page: 1455 year: 2000 ident: 1769_CR42 publication-title: Arch Intern Med. doi: 10.1001/archinte.160.10.1455 – volume: 334 start-page: 1435 year: 1996 ident: 1769_CR49 publication-title: N Engl J Med doi: 10.1056/NEJM199605303342204 – volume: 26 start-page: 1 year: 2014 ident: 1769_CR2 publication-title: Dig Endosc doi: 10.1111/den.12183 – volume: 17 start-page: 286 year: 2012 ident: 1769_CR46 publication-title: Helicobacter doi: 10.1111/j.1523-5378.2012.00942.x – volume: 40 start-page: 780 year: 2014 ident: 1769_CR79 publication-title: Aliment Pharmacol Ther doi: 10.1111/apt.12907 – volume: 34 start-page: 762 year: 1993 ident: 1769_CR94 publication-title: Gut doi: 10.1136/gut.34.6.762 – volume: 88 start-page: 1054 year: 2001 ident: 1769_CR105 publication-title: Br J Surg doi: 10.1046/j.0007-1323.2001.01831.x – volume: 67 start-page: 1033 year: 2018 ident: 1769_CR7 publication-title: Gut doi: 10.1136/gutjnl-2017-314852 – volume: 3 start-page: 231 year: 2018 ident: 1769_CR50 publication-title: Lancet Gastroenterol Hepatol doi: 10.1016/S2468-1253(18)30037-2 – volume: 151 start-page: 1105 year: 2016 ident: 1769_CR20 publication-title: Gastroenterology doi: 10.1053/j.gastro.2016.08.054 – volume: 31 start-page: S54 issue: Suppl 1 year: 1999 ident: 1769_CR47 publication-title: Ital J Gastroenterol Hepatol – volume: 12 start-page: 317 year: 2007 ident: 1769_CR22 publication-title: Helicobacter doi: 10.1111/j.1523-5378.2007.00508.x |
| SSID | ssj0013058 |
| Score | 2.6502542 |
| SecondaryResourceType | review_article |
| Snippet | The Japanese Society of Gastroenterology (JSGE) revised the third edition of evidence-based clinical practice guidelines for peptic ulcer disease in 2020 and... |
| SourceID | pubmedcentral proquest gale pubmed crossref springer |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 303 |
| SubjectTerms | Abdominal Surgery Algorithms Anti-Bacterial Agents - therapeutic use Antibiotics Antiulcer drugs Aspirin Associations, institutions, etc Care and treatment Celecoxib Clinical medicine Clinical practice guidelines Clopidogrel Colorectal Surgery Dosage Epidemiology Evidence-based medicine Evidence-Based Practice - methods Gastroenterology Health aspects Helicobacter pylori Hemorrhage Hepatology Histamine Humans Inflammation Japan Medicine Medicine & Public Health Metronidazole Nonsteroidal anti-inflammatory drugs Patients Peptic ulcer Peptic Ulcer - complications Peptic Ulcer - therapy Peptic ulcers Prevention Proton pump inhibitors Proton Pump Inhibitors - therapeutic use Review Societies Stenosis Surgical Oncology Ulcers |
| SummonAdditionalLinks | – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3dS8MwEA8yQXwRv61OiSD4oIF-JW0fx3BMYT5N2FtY0lSFUcdc_3_vsrSzQwWfc02Ty13uwt39jpAbPzKF0glnfqEVi7WIWZoVhnFlm6gWoW_7p4yexfAlfprwiYPJwVqYjfg9gn3yCGuI8dGbiIzB83ybw8WL0twX_XXEwLe9OOG1ErMA3GxXIPPzHC0jtHkVf7NFm3mSG8FSa4MG-2TPOY-0tzrtA7JlykOyM3Lh8SPyWPcIZWicclqXPdK6Foq-VghrhanuFLxVOsecFk2rmTYL6mI1NATf7piMBw_j_pC5XglMiyhYMqPgXZBwsMdaaePnIQKtJTyJRJ6CR2SCzELdCW5MpkGt46lCKngfpiotiuiEdMqP0pwRGhhgLy-CMDcaweRTJXQOt0A45SrmReaRoOad1A5HHNtZzGSDgGz5LYHf0vJb-h65a76Zr1A0_qS-xSORqGIws566SgFYH4JVyV4SYLQv87lHui1KUA3dHq4PVTrV_JTg8wlwg0UGO7luhvFLTDcrzUcFNAijKMC4wxSnKxlo1h2ByQdZEx5JWtLRECBgd3ukfH-zwN0pbhX_e1_L0XpZv7Pj_H_kF2Q3tKKO2UVd0lkuKnMJjtNSXVmN-QKoZgnm priority: 102 providerName: Springer Nature |
| Title | Evidence-based clinical practice guidelines for peptic ulcer disease 2020 |
| URI | https://link.springer.com/article/10.1007/s00535-021-01769-0 https://www.ncbi.nlm.nih.gov/pubmed/33620586 https://www.proquest.com/docview/2506115699 https://www.proquest.com/docview/2492660365 https://pubmed.ncbi.nlm.nih.gov/PMC8005399 |
| Volume | 56 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9swED-2FsZeRrtPd23RYLCHTcyyLdl-KklI1m00jNFC9iQiWe4GxUnb5P_fnSI7c2B9sR90tuXzne7ku_sdwPs4dbWxueRxbQ3PrMp4UdaOS-ObqNZJ7PunXEzV-VX2bSZn4YfbfUirbNdEv1BXC0v_yD-jqVbovaiyPFvecuoaRdHV0ELjMewL9ESodUM-y7dRhNj358QdTMYFut6haMaXznlgE04JCiiTquRxzzDtLs__2Kfd3MmdAKq3S5MDeBYcSjbYSMAhPHLNc3hyEULmL-Br2zeUk8GqWFsKydr6KHa9JqgrSn9n6MGyJeW5WLa-se6OhfgNS9DfewmXk_Hl6JyH_gncqlSsuDO4V8gl2mhrrIurhMDXcpmnqirQS3Ki9PB3SjpXWlT1bG6ICveMhSnqOn0Fe82icW-ACSdFKmuRVM4SwHxhlK1wZUjm0mSyLiMQLe-0Ddji1OLiRneoyJ7fGvmtPb91HMHH7prlBlnjQeoP9Ek0qR3e2c5D9QDOjwCs9CAXFAEsYxnBcY8S1cX2h9uPqoO63uutcEXwrhumKykFrXGLNdIQtKJCg4-3eL2RgW7eKboBKGsqgrwnHR0BgXj3R5o_vz2Yd0GvSs_91MrRdlr_Z8fRw2_xFp4mXrQpw-gY9lZ3a3eCztPKnHoNOYX9wWQ4nNL5y6_vYzwPx9MfP3F0pEZ4vEoGfwHg4xeZ |
| linkProvider | ProQuest |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NTgJe0PgObGAkEA9gLV92kodpGrCpZWuFUJH2ZtWOwyZNadlaIf44_jfuXCddKrG3PfviOOc73zl39zuAt2FiK20ywcPKaJ4amfK8qCwX2jVRreLQ9U8ZjmT_R_r1VJxuwN-mFobSKpsz0R3U5dTQP_JdNNUSvRdZFPuzX5y6RlF0tWmhMfGtFco9BzHmCzuO7Z_feIW72ht8wf1-F8dHh-PPfe67DHAjk2jOrUaPOhNoyYw2NixjgijLRJbIMkdfwkaFA4mTwtrCoEKkE01UeLPKdV5VCU57BzZT-n_Sg81Ph6Nv31dhjNA1CMUrVMoj9P191Y6r3XPIKpwyJFApZMHDjmVctw_XDOR68uZaBNcZxqMteOA9WnawFMGHsGHrR3B36GP2j2HQNC7lZDFL1tRisqZAi_1cENYW5d8zdKHZjBJtDFtcGHvJfACJxehwPoHxbbD2KfTqaW2fA4usiBJRRXFpDSHc51qaEo-meCJ0KqoigKjhnTIe3Jx6bFyoFpbZ8Vshv5XjtwoD-NA-M1tCe9xI_Z62RJHe48xm4ssXcH2EoKUOsohCkEUoAtjuUKK-mu5ws6nKnxdXaiXdAbxph-lJyoGr7XSBNITtKNHjwCmeLWWgXXeCfgjKmgwg60hHS0Ao4t2R-vzMoYnn9Kn03o-NHK2W9X92vLj5K17Dvf54eKJOBqPjl3A_dmJO6U7b0JtfLuwOenJz_crrCwN1yxr6D9hxUlU |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3dbxMxDLfGkCZeEN87GBAkEA8Q7b6Su3tAaGJUK2MTD0PqW9TkEkCarmVrhfjT-O-w0-TKVWJve218ac6xY-ds_wzwMi2s06YSPHVG89LIkteNs1xo30TV5anvn3JyKo--lp8mYrIFf2ItDKVVxjPRH9TtzNA38n001RK9F9k0-y6kRXw5HL2f_-TUQYoirbGdxkpEju3vX3h9u3w3PsS9fpXno49nH4546DDAjSyyBbcavelKoBUz2ti0zQmerBJVIdsa_QibNR4gTgprG4PKUE41UeGtqta1cwVOewNu4u8ldY2oJtU6gJH61qB4eSp5hl5_qNfxVXseU4VTbgSqg2x4OrCJm5bhH9O4mba5Ebv1JnF0B24HX5YdrITvLmzZ7h7snIRo_X0Yx5alnGxly2IVJoulWezbklC2KPOeofPM5pRiY9jy3NgLFkJHLEdX8wGcXQdjH8J2N-vsLrDMiqwQLstbawjbvtbStHgo5VOhS-GaBLLIO2UCrDl11zhXPSCz57dCfivPb5Um8KZ_Zr4C9biS-jVtiSKNx5nNNBQu4PoIO0sdVBkFH5tUJLA3oERNNcPhuKkqnBSXai3XCbzoh-lJyn7r7GyJNITqKNHXwCkerWSgX3eBHgjKmkygGkhHT0D44cOR7sd3jyNe06vS_76NcrRe1v_Z8fjqt3gOO6iX6vP49PgJ3Mq9lFOe0x5sLy6W9im6cAv9zCsLA3XNyvkXeMJP8Q |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evidence-based+clinical+practice+guidelines+for+peptic+ulcer+disease+2020&rft.jtitle=Journal+of+gastroenterology&rft.au=Kamada%2C+Tomoari&rft.au=Satoh%2C+Kiichi&rft.au=Itoh%2C+Toshiyuki&rft.au=Ito%2C+Masanori&rft.date=2021-04-01&rft.pub=Springer&rft.issn=0944-1174&rft.volume=56&rft.issue=4&rft.spage=303&rft_id=info:doi/10.1007%2Fs00535-021-01769-0&rft.externalDocID=A714582905 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0944-1174&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0944-1174&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0944-1174&client=summon |